by jlohrconsulting | Oct 1, 2025 | Uncategorized
Acad Radiol. 2025 Sep 29:S1076-6332(25)00713-5. doi: 10.1016/j.acra.2025.07.043. Online ahead of print. ABSTRACT RATIONALE AND OBJECTIVES: Cancer-related fatigue (CRF) is a common and persistent symptom in primary liver cancer patients undergoing transarterial...
by jlohrconsulting | Oct 1, 2025 | Uncategorized
AIDS Care. 2025 Sep 30:1-10. doi: 10.1080/09540121.2025.2565425. Online ahead of print. ABSTRACT An evidence-based self-help program in booklet format has been developed to reduce depressive symptoms among people living with HIV (PLWH) in Botswana. Its effectiveness...
by jlohrconsulting | Oct 1, 2025 | Uncategorized
Biomol Ther (Seoul). 2025 Oct 1. doi: 10.4062/biomolther.2025.046. Online ahead of print. ABSTRACT Suzetrigine is a novel non-opioid analgesic that selectively inhibits the Nav1.8 sodium channel, which plays a key role in peripheral pain signaling. By blocking action...
by jlohrconsulting | Oct 1, 2025 | Uncategorized
Nat Commun. 2025 Sep 30;16(1):8657. doi: 10.1038/s41467-025-63818-z. ABSTRACT Cortical populations are in a broadly asynchronous state that is sporadically interrupted by brief epochs of coordinated population activity. Inhibitory stabilized networks reproduce a low...
by jlohrconsulting | Oct 1, 2025 | Uncategorized
Sci Rep. 2025 Sep 30;15(1):33881. doi: 10.1038/s41598-025-08460-x. ABSTRACT Patient-reported drug responses offer an alternative approach to design and develop a predictive model for treatment-resistant depression (TRD) in major depressive disorder (MDD). The...
by jlohrconsulting | Oct 1, 2025 | Uncategorized
Sci Rep. 2025 Sep 30;15(1):33841. doi: 10.1038/s41598-025-03847-2. ABSTRACT Post-stroke depression (PSD) is a prevalent condition that significantly affects stroke recovery and increases healthcare costs. Early identification of depressive symptoms and individuals at...
Recent Comments